Blackstone’s Artiva Biotherapeutics ARTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.3M Buy
+2,403,437
New +$21.9M 0.06% 72

Other funds holding ARTV

Blackstone's ARTV Position: Q2 2026 in Review

Blackstone opened a new position in Artiva Biotherapeutics (ARTV) in Q2 2026: 2,403,437 shares worth $23.3M. The stake represents 0.06% of the portfolio and ranks #72 among its holdings.

72 funds tracked by Wall St. Rank hold ARTV as of Q2 2026.

  • Blackstone held 2,403,437 shares of Artiva Biotherapeutics worth $23.3M as of Q2 2026.
  • Artiva Biotherapeutics was a new Blackstone position in Q2 2026.
  • Artiva Biotherapeutics made up 0.06% of Blackstone's portfolio in Q2 2026, its #72 holding.
  • 72 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q2 2026.

Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.